283 related articles for article (PubMed ID: 9989495)
1. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.
Willis TG; Jadayel DM; Du MQ; Peng H; Perry AR; Abdul-Rauf M; Price H; Karran L; Majekodunmi O; Wlodarska I; Pan L; Crook T; Hamoudi R; Isaacson PG; Dyer MJ
Cell; 1999 Jan; 96(1):35-45. PubMed ID: 9989495
[TBL] [Abstract][Full Text] [Related]
2. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).
Zhang Q; Siebert R; Yan M; Hinzmann B; Cui X; Xue L; Rakestraw KM; Naeve CW; Beckmann G; Weisenburger DD; Sanger WG; Nowotny H; Vesely M; Callet-Bauchu E; Salles G; Dixit VM; Rosenthal A; Schlegelberger B; Morris SW
Nat Genet; 1999 May; 22(1):63-8. PubMed ID: 10319863
[TBL] [Abstract][Full Text] [Related]
3. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
[TBL] [Abstract][Full Text] [Related]
4. BCL10 gene mutation in lymphoma.
Du MQ; Peng H; Liu H; Hamoudi RA; Diss TC; Willis TG; Ye H; Dogan A; Wotherspoon AC; Dyer MJ; Isaacson PG
Blood; 2000 Jun; 95(12):3885-90. PubMed ID: 10845924
[TBL] [Abstract][Full Text] [Related]
5. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
6. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression.
Maes B; Demunter A; Peeters B; De Wolf-Peeters C
Blood; 2002 Feb; 99(4):1398-404. PubMed ID: 11830492
[TBL] [Abstract][Full Text] [Related]
7. MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells.
Sagaert X; Laurent M; Baens M; Wlodarska I; De Wolf-Peeters C
Mod Pathol; 2006 Feb; 19(2):225-32. PubMed ID: 16341151
[TBL] [Abstract][Full Text] [Related]
8. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G
J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391
[TBL] [Abstract][Full Text] [Related]
9. BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.
Bullinger L; Leupolt E; Schaffner C; Mertens D; Bentz M; Lichter P; Döhner H; Stilgenbauer S
Leukemia; 2000 Aug; 14(8):1490-2. PubMed ID: 10942247
[TBL] [Abstract][Full Text] [Related]
10. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
[TBL] [Abstract][Full Text] [Related]
11. Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.
Takahashi H; Hosokawa Y; Suzuki R; Morishima Y; Nakamura S; Seto M
Jpn J Cancer Res; 1999 Dec; 90(12):1316-20. PubMed ID: 10665648
[TBL] [Abstract][Full Text] [Related]
12. Aggressive mucosa associated lymphoid tissue lymphomas are associated with mutations in Bcl10.
Spencer J
Gut; 1999 Jun; 44(6):778-9. PubMed ID: 10323877
[No Abstract] [Full Text] [Related]
13. Novel translocation of the BCL10 gene in a case of mucosa associated lymphoid tissue lymphoma.
Achuthan R; Bell SM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
Genes Chromosomes Cancer; 2000 Dec; 29(4):347-9. PubMed ID: 11066079
[TBL] [Abstract][Full Text] [Related]
14. BCL10 expression and localization in ocular adnexa MALT lymphomas: a comparative cytogenetic and immunohistochemical study.
Cerrone M; Collina F; De Chiara A; Corazzelli G; Curcio MP; De Renzo A; Russo F; Cantile M; Staibano S; Strianese D; Tranfa F; Botti G; De Rosa G; Franco R
Histol Histopathol; 2014 Jan; 29(1):77-87. PubMed ID: 23846624
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.
Hamoudi RA; Appert A; Ye H; Ruskone-Fourmestraux A; Streubel B; Chott A; Raderer M; Gong L; Wlodarska I; De Wolf-Peeters C; MacLennan KA; de Leval L; Isaacson PG; Du MQ
Leukemia; 2010 Aug; 24(8):1487-97. PubMed ID: 20520640
[TBL] [Abstract][Full Text] [Related]
16. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.
Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P
J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026
[TBL] [Abstract][Full Text] [Related]
17. MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10.
Nakagawa M; Hosokawa Y; Yonezumi M; Izumiyama K; Suzuki R; Tsuzuki S; Asaka M; Seto M
Blood; 2005 Dec; 106(13):4210-6. PubMed ID: 16123224
[TBL] [Abstract][Full Text] [Related]
18. [New Bcl10 regulation mechanisms: a step in the comprehension of what has occurred in MALT lymphomas?].
Lobry C; Weil R
Med Sci (Paris); 2007 Apr; 23(4):353-5. PubMed ID: 17433222
[No Abstract] [Full Text] [Related]
19. BCL10 somatic mutations rarely occur in gastric lymphoma: detection of high frequency of polymorphisms in BCL10 coding region.
Chen YW; Wong KY; Au WY; Liang RH; Srivastava G
Cancer Genet Cytogenet; 2001 Jun; 127(2):184-7. PubMed ID: 11425462
[TBL] [Abstract][Full Text] [Related]
20. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
Hosokawa Y
Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]